Kim S S, Smith T J, Chapman M S, Rossmann M C, Pevear D C, Dutko F J, Felock P J, Diana G D, McKinlay M A
Department of Biological Sciences, Purdue University, West Lafayette, IN 47907.
J Mol Biol. 1989 Nov 5;210(1):91-111. doi: 10.1016/0022-2836(89)90293-3.
The structure of human rhinovirus 1A (HRV1A) has been determined to 3.2 A resolution using phase refinement and extension by symmetry averaging starting with phases at 5 A resolution calculated from the known human rhinovirus 14 (HRV14) structure. The polypeptide backbone structures of HRV1A and HRV14 are similar, but the exposed surfaces are rather different. Differential charge distribution of amino acid residues in the "canyon", the putative receptor binding site, provides a possible explanation for the difference in minor versus major receptor group specificities, represented by HRV1A and HRV14, respectively. The hydrophobic pocket in VP1, into which antiviral compounds bind, is in an "open" conformation similar to that observed in drug-bound HRV14. Drug binding in HRV1A does not induce extensive conformational changes, in contrast to the case of HRV14.
利用相位精修和对称平均扩展法,从已知的人鼻病毒14(HRV14)结构计算出的5埃分辨率的相位开始,已将人鼻病毒1A(HRV1A)的结构解析到3.2埃分辨率。HRV1A和HRV14的多肽主链结构相似,但暴露表面差异较大。“峡谷”(假定的受体结合位点)中氨基酸残基的电荷分布差异,为分别由HRV1A和HRV14代表的次要与主要受体组特异性差异提供了一种可能的解释。抗病毒化合物结合的VP1中的疏水口袋处于与在药物结合的HRV14中观察到的类似的“开放”构象。与HRV14的情况相反,HRV1A中的药物结合不会诱导广泛的构象变化。